- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x MBK: ~{N}-[6-(4-azanylbutylamino)-1-[(4-bromophenyl)methyl]-2,4-bis(oxidanylidene)pyrimidin-5-yl]-~{N}-methyl-benzenesulfonamide(Non-covalent)
- 2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
MES.2: 8 residues within 4Å:- Chain A: F.160, G.164, K.165, A.166, S.223, V.224, I.226
- Chain D: Y.303
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:A.166, A:V.224
- Water bridges: A:I.226
- Salt bridges: A:K.165
MES.9: 9 residues within 4Å:- Chain B: F.160, G.164, K.165, A.166, L.222, S.223, V.224, I.226
- Chain C: Y.303
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:A.166, B:V.224
- 1 x BR: BROMIDE ION(Non-covalent)
- 14 x CL: CHLORIDE ION(Non-functional Binders)
CL.4: 5 residues within 4Å:- Chain A: L.18, G.20, K.35, G.119, D.120
Ligand excluded by PLIPCL.5: 4 residues within 4Å:- Chain A: H.126
- Chain D: G.228, R.229, G.230
Ligand excluded by PLIPCL.6: 5 residues within 4Å:- Chain A: G.228, R.229, G.230
- Chain D: H.126
- Ligands: MBK.17
Ligand excluded by PLIPCL.7: 4 residues within 4Å:- Chain A: R.269, E.300, T.301, V.302
Ligand excluded by PLIPCL.10: 5 residues within 4Å:- Chain B: H.126
- Chain C: G.228, R.229, G.230
- Ligands: MBK.8
Ligand excluded by PLIPCL.11: 3 residues within 4Å:- Chain B: V.182, T.210, N.213
Ligand excluded by PLIPCL.12: 5 residues within 4Å:- Chain B: G.228, R.229, G.230
- Chain C: H.126
- Ligands: MBK.13
Ligand excluded by PLIPCL.14: 3 residues within 4Å:- Chain C: V.182, T.210, N.213
Ligand excluded by PLIPCL.15: 4 residues within 4Å:- Chain C: K.259, G.289, Y.290
- Chain D: H.239
Ligand excluded by PLIPCL.16: 2 residues within 4Å:- Chain C: T.238, H.239
Ligand excluded by PLIPCL.18: 2 residues within 4Å:- Chain D: G.21, G.23
Ligand excluded by PLIPCL.19: 4 residues within 4Å:- Chain A: R.255
- Chain D: V.149, D.151, R.154
Ligand excluded by PLIPCL.20: 3 residues within 4Å:- Chain D: V.182, T.210, N.213
Ligand excluded by PLIPCL.21: 6 residues within 4Å:- Chain D: L.18, G.20, K.35, Q.36, G.119, D.120
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiao, G. et al., Next generation Glucose-1-phosphate thymidylyltransferase (RmlA) inhibitors: An extended SAR study to direct future design. Bioorg.Med.Chem. (2021)
- Release Date
- 2020-08-19
- Peptides
- Glucose-1-phosphate thymidylyltransferase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x MBK: ~{N}-[6-(4-azanylbutylamino)-1-[(4-bromophenyl)methyl]-2,4-bis(oxidanylidene)pyrimidin-5-yl]-~{N}-methyl-benzenesulfonamide(Non-covalent)
- 2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
- 1 x BR: BROMIDE ION(Non-covalent)
- 14 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiao, G. et al., Next generation Glucose-1-phosphate thymidylyltransferase (RmlA) inhibitors: An extended SAR study to direct future design. Bioorg.Med.Chem. (2021)
- Release Date
- 2020-08-19
- Peptides
- Glucose-1-phosphate thymidylyltransferase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D